Apomorphine
Check on isomerdesign
Apomorphine
Check on pubchem
Apomorphine
Check on drugmap
Apomorphine
Check on drugmap
Apomorphine
Check on wiki
Data
InChI: InChI=1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3
Synonyms: APOMORPHINE6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol,(9R)-10-methyl-10-azatetracyclo[7.7.1.0?,?.0??,??]heptadeca-1(16),2,4,6,13(17),14-hexaene-3,4-diol,N21FAR7B4S,EN300-18161186, ZINC155525,Apomorphine hydrochloride hemihydrate,DTXSID8022614,Prestwick0_000101,HMS2089C10,NCGC00025349-05,NCGC00025349-03,(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol,NCGC00025349-01, cid_6852389,41372-20-7,Apomorphine (R,-),APOMORPHINE [WHO-DD],PDSP2_001488,Tox21_110967,BSPBio_000082,EINECS 200-360-0,(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol ((R)-apomorphine),NCGC00025349-02, UNII-LH812IV7LI, Apomorphine, S-,HSDB 3289,DSSTox_CID_2614,DSSTox_RID_76660,VR040,apomorphine,372A207,D07460,BPBio1_000092,(R)-5,6,6A,7-TETRAHYDRO-6-METHYL-4H-DIBENZO[DE-G]QUINOLINE-10,11-DIOL, (6as)-10,11-dihydroxyaporphine,APOMORPHINE [MI],Prestwick1_000101, S(+)-APOMORPHINE,SCHEMBL8541, GTPL8285, Lopac-A-4393,Apomorphinium chloride hemihydrate,L-Apomorphine,Apomorphine (intranasal, Parkinson's disease),6a-beta-Aporphine-10,11-diol,Apokyn,(S)APOMORPHINE,Apomorphine free base,Tox21_110967_1, CTK1C3986,ZINC9073,(R)-5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol,BRD-K76022557-311-20-6,6abeta-Aporphine-10,11-diol, AC1LEHBI,5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo-[de,g]quinoline-10,11-diol,Tocris-2073,(6aR)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo(de,g)chinolin-10,11-diol,SMP1_000027, DTXSID40192615,Apomorphinum, PDSP1_001504, LH812IV7LI,BPBio1_001179,CAS-58-00-4,(6AR)-5,6,6A,7-TETRAHYDRO-6-METHYL-4H-DIBENZO(DE,G)QUINOLINE-10,11-DIOL, Oprea1_044402,(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol(apomorphine),(-)6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol(APO),6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol((R)-apomorphine),(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol, CHEMBL416288, (+)-10,11-Dihydroxyaporphine,58-00-4,PDSP1_000780,APOMORPHINUM [HPUS],APL-130277,Ixense,(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol;hydrate;hydrochloride,Q269111,(9R)-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(16),2(7),3,5,13(17),14-hexaene-3,4-diol,GTPL33,(-)-10,11-Dihydroxyaporphine,VR-400,VR-040,APOMORPHINE [VANDF],R-(-)-Apomorphine,Biomol-NT_000019,SPBio_002021, MolPort-002-507-063,Uprima,(9R)-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,13,15-hexaene-3,4-diol,Apomorphine hydrochloride,Apomorphine (BAN),(apomorphine)6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol,(Apomorphine) 6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol,CHEBI:48538, 39478-62-1,APOMORPHINE [HSDB],(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol (apomorphine),6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol ((R)-apomorphine),Apomorphine [BAN],6a.beta.-aporphine-10,11-diol,(R)-(-)-Apomorphine,DSSTox_GSID_22614,Kynmobi (sublingual film),BRD-K76022557-001-01-3,4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (R)-,Apomorphine,Q-200645,NCGC00025349-04,Uprima (TN),UNII-N21FAR7B4S,58-00-4 (free base), SCHEMBL6922802,Apormorphine,cid_6852399,VR004,Prestwick2_000101,NH001,Prestwick3_000101,(-)-Apomorphine,CHEMBL53, (6aS)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol,BDBM29644,Apomorphin, BDBM29643,Apomorfin,S-(+)-apomorphine,BDBM50001955, 4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (S)-,DB00714,OR9, S-apomorphine
Estimated data
Solubility: -3.216 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: No (prediction using frontiersin.org)
Addictivity Prediction: 35.6% (prediction based on www.mdpi.com)
